Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
![]() |
![]() ![]() |
Ultima descărcare din IBN: 2021-11-24 14:23 |
Căutarea după subiecte similare conform CZU |
616.98:578.834.1-078 (1) |
Инфекционные заболевания. Инфекционные лихорадки (587) |
Вирусология (446) |
![]() SPÎNU, Constantin, CEBOTARI, Svetlana, SAJIN, Octavian, SPÎNU, Igor, DONOS, Ala, VOLNEANSCHI, Ana, GOSTEV, Igor, DOPIRA, Iurie. Evaluarea prezenței anticorpilor anti SARS-CoV- 2 la donatorii de plasmă convalescentă cu scopul de a argumenta utilizarea lor în tratamentul COVID-19. In: One Health and Risk Management, 2021, nr. 2(2), pp. 58-64. ISSN 2587-3458. DOI: https://doi.org/10.38045/ohrm.2021.2.08 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
One Health and Risk Management | ||
Numărul 2(2) / 2021 / ISSN 2587-3458 /ISSNe 2587-3466 | ||
|
||
DOI:https://doi.org/10.38045/ohrm.2021.2.08 | ||
CZU: 616.98:578.834.1-078 | ||
Pag. 58-64 | ||
![]() |
||
Rezumat | ||
Introduction. Currently, COVID-19 treatment includes several options, including the use of convalescent plasma. Therefore, the presence of anti-SARS-CoV-2 in blood donors after the clinical recovery of COVID-19, depending on their place of residence, age and the clinical manifestation of the disease is of scientific-practical interest. Material and methods. A total of 119 donors among patients were examined, namely males aged 18-60 years, having a past history of COVID-19 disease, being confirmed by PCR and treated, showing a negative PCR-based test result, which was performed at least 14 days after clinical recovery. The presence/absence of anti-SARS-CoV-2 was assessed by enzyme-linked immunosorbent assay. Results. The obtained data showed that 87.4% of plasma donors responded to COVID-19 infection by anti-SARS-CoV-2 IgG expression, being predominantly found in the 26-35 age group. Most donors experienced mild and medium clinical forms. It is important to note that all severe clinical manifestations of the infection were followed by formation of antiSARS-CoV-2 IgG. Urban living environment was predominantly found in convalescent donors (75.0%), which indicates that they are better informed by medical institutions. Conclusions. The study shows that male blood donors aged 18-60 years, subsequently cured and being positive to anti-SARS-CoV-2 IgG can serve as a source of fresh plasma used for the treatment of COVID-19 patients. |
||
Cuvinte-cheie COVID-19 treatment, plasma donors, anti SARSCoV2, IgG class antibodies, tratamentul COVID-19, plasma donatorilor, anti SARS-CoV-2, anticorpi IgG |
||
|
Crossref XML Export
<?xml version='1.0' encoding='utf-8'?> <doi_batch version='4.3.7' xmlns='http://www.crossref.org/schema/4.3.7' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.crossref.org/schema/4.3.7 http://www.crossref.org/schema/deposit/crossref4.3.7.xsd'> <head> <doi_batch_id>ibn-126804</doi_batch_id> <timestamp>1719689593</timestamp> <depositor> <depositor_name>Information Society Development Instiute, Republic of Moldova</depositor_name> <email_address>[email protected]</email_address> </depositor> <registrant>Asociația de Biosiguranță și Biosecuritate din Republica Moldova</registrant> </head> <body> <journal> <journal_metadata> <full_title>One Health and Risk Management</full_title> <issn media_type='print'>25873458</issn> </journal_metadata> <journal_issue> <publication_date media_type='print'> <year>2021</year> </publication_date> <issue>2(2)</issue> </journal_issue> <journal_article publication_type='full_text'><titles> <title>Evaluarea prezenței anticorpilor anti SARS-CoV- 2 la donatorii de plasmă convalescentă cu scopul de a argumenta utilizarea lor în tratamentul COVID-19</title> </titles> <contributors> <person_name sequence='first' contributor_role='author'> <given_name>Constantin</given_name> <surname>Spînu</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Svetlana</given_name> <surname>Cebotari</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Octavian</given_name> <surname>Sajin</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Igor</given_name> <surname>Spînu</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Ala</given_name> <surname>Donos</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Ana</given_name> <surname>Volneanschi</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Igor</given_name> <surname>Gostev</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Iurie</given_name> <surname>Dopira</surname> </person_name> </contributors> <publication_date media_type='print'> <year>2021</year> </publication_date> <pages> <first_page>58</first_page> <last_page>64</last_page> </pages> <doi_data> <doi>10.38045/ohrm.2021.2.08</doi> <resource>http://www.crossref.org/</resource> </doi_data> </journal_article> </journal> </body> </doi_batch>